spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Varian 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 31 Dec 2024
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Dec 2024
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY(TM) (crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
Diagnostics Product Launch
 HSMN NewsFeed - 24 Oct 2024
Pillar Biosciences Receives CPT(R) Code for FDA Approved oncoReveal(TM) CDx Pan-Cancer Solid tumor IVD Kit
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 24 Oct 2024
Accent Therapeutics Announces FDA Clearance of IND Application for ATX-559, a First-In-Class Oral DHX9 Inhibitor
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Oct 2024
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Sep 2024
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
Devices Oncology
 HSMN NewsFeed - 20 Aug 2024
RYBREVANT(R) (amivantamab-vmjw) Plus LAZCLUZE(TM) (lazertinib) Approved in the U.S. as a First-line Chemotherapy-free Treatment for Patients with EGFR-mutated Advanced Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Apr 2024
TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 13 Feb 2024
ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Feb 2024
AbbVie Completes Acquisition of ImmunoGen
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2024
TORL BioTherapeutics Announces Appointment of Mark J. Alles as Chairman and Chief Executive Officer; Highlights Significant Progress of its Oncology Clinical Programs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2023
Antiva Biosciences Strengthens Leadership with Key New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2023
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 24 May 2023
RayCare is interoperable with Varian TrueBeam
Devices Oncology
 HSMN NewsFeed - 20 Apr 2023
IceCure's ProSense System Used in Endometriosis Cryoablation Study That Demonstrated Efficacy Rate of 92.8% to Avoid Secondary Surgery
Devices Interventional
 HSMN NewsFeed - 16 Feb 2023
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 27 Dec 2022
Koya Medical Announces the Addition of Chief Medical Officer Dr. Thomas Maldonado to Their Executive Leadership Team
Devices Personnel
 HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Nov 2022
Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure(R) Predict Prognostic Test for Alzheimer's Disease
Diagnostics Neurology Personnel
 HSMN NewsFeed - 18 Oct 2022
FDA Approves First IND of its Kind for Allogenic Exosomal Treatment of Female Reproductive Disorder - Primary Ovarian Insufficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Sep 2022
Marengo Therapeutics Advances First-In-Class Selective T cell Activator, STAR0602, into Human Trials in Solid Tumors and Enters Cooperative Research and Development Agreement with the National Cancer Institute
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Aug 2022
Calyptus Pharmaceuticals Announces FDA Approval of Cetrorelix Acetate for Injection, 0.25 mg/vial
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Aug 2022
Verismo Therapeutics Announces Submission of IND Application to the FDA for SynKIR-110TM, a KIR-CAR T-cell Immunotherapy Candidate
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Aug 2022
U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Jul 2022
Bausch & Lomb Provides Leadership Update
Devices Ophthalmology Personnel
 HSMN NewsFeed - 23 Jun 2022
CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jun 2022
Caris Life Sciences Introduces the Caris Assure(TM) Liquid Biopsy Assay at ASCO 2022
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 18 May 2022
Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Apr 2022
Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental Disorders
Diagnostics Product Launch
 HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 28 Mar 2022
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2022
Sky Medical Technology wins further FDA clearance to market the new (W3) geko(TM) device variant for venous insufficiency and ischemia
Devices FDA
 HSMN NewsFeed - 28 Dec 2021
Petros Pharmaceuticals Announces Closing of $7.5 Million Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Dec 2021
Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1(TM) Implant System
Devices Dental FDA
 HSMN NewsFeed - 20 Dec 2021
CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb(R) in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)
Devices
 HSMN NewsFeed - 29 Nov 2021
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 Nov 2021
Kintara Announces Changes to Executive Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2021
Marengo Therapeutics Launches with $80M from ATP, Appoints CEO Zhen Su, MD, to Deliver Breakthrough Cancer Treatments Using Its Selective T Cell Activation Repertoire (STAR) Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Nov 2021
Theseus Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for THE-630, a Pan-Variant KIT Inhibitor in Development for the Treatment of Gastrointestinal Stromal Tumors (GIST)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Oct 2021
Iridium Network invests in RayCare to become their primary oncology information system
Devices Oncology
 HSMN NewsFeed - 15 Oct 2021
SpinaFX Medical announces John Soloninka as Chief Operating Officer
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 13 Oct 2021
Varian Receives FDA "Breakthrough Device Designation" For Embozene(R) Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis
Devices Interventional FDA
 HSMN NewsFeed - 27 Sep 2021
Synlogic Appoints Molly Harper as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2021
Kintara Reports Topline Results from Phase 2 Clinical Study of VAL-083 as Adjuvant Therapy for Newly-Diagnosed GBM Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2021
Sutro Biopharma Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Aug 2021
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Aug 2021
Rigel Pharmaceuticals Provides Update on COVID-19 Program
Biopharmaceuticals
 HSMN NewsFeed - 9 Aug 2021
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Aug 2021
BioInvent Announces Second Clinical Trial Collaboration and Supply Agreement to Evaluate BI-1808 in Combination with KEYTRUDA(R) (pembrolizumab) in Patients with Advanced Solid Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Aug 2021
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jul 2021
PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
Diagnostics Regulatory
 HSMN NewsFeed - 8 Jul 2021
Elevar Therapeutics Announces New Appointments to Strengthen its Executive and Senior Leadership Teams
Biopharmaceutical Personnel
 HSMN NewsFeed - 8 Jul 2021
Theolytics expands Series A financing and welcomes M Ventures as a new investor
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jun 2021
FDA Grants Fast Track Designation to CNS Pharmaceuticals for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Jun 2021
Macrophage Pharma Appoints Dr Venkat Reddy as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2021
Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)
Devices Cardiology FDA
 HSMN NewsFeed - 13 May 2021
SpliSense Secures $28.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 May 2021
Theseus Pharmaceuticals Appoints Tim Clackson, Ph.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Apr 2021
GLOBAL Sarcoma Therapy Now Approved for Australian Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Apr 2021
Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Apr 2021
GlobalMed Introduces the TotalExam(R) Lite, the Next Generation of Digital General Exam Cameras and Otoscopes for Telemedicine
Devices Product Launch
 HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Mar 2021
COVID-19 Antibody Tests For Variants Now Available Worldwide
Diagnostics Product Launch
 HSMN NewsFeed - 22 Mar 2021
Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2021
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2021
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Mar 2021
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
Diagnostics FDA
 HSMN NewsFeed - 4 Mar 2021
Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG(R) Respiratory Panel Test Including SARS-CoV-2
Diagnostics FDA Regulatory
 HSMN NewsFeed - 2 Mar 2021
Varian Announces CEO Succession Plan
Devices Oncology Personnel Mergers & Acquisitions
 HSMN NewsFeed - 23 Feb 2021
Elicio Therapeutics Announces FDA Clearance of IND application for ELI-002-- A Therapeutic Vaccine Targeting mutated KRAS Cancers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Feb 2021
BD Announces Emergency Use Authorization, CE Mark for Combination Molecular Diagnostic to Detect SARS-CoV-2, Influenza A+B in Single Test
Diagnostics FDA Regulatory
 HSMN NewsFeed - 1 Feb 2021
New Scientific Publications Show Diadem's Blood-Based AlzoSure(R) Biomarker Test Can Predict Which Patients Will Progress to Alzheimer's Disease Years Before Symptoms Occur
Diagnostics Neurology
 HSMN NewsFeed - 27 Jan 2021
Nuvalent Launches with $50M Series A Financing from Deerfield Management to Develop Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 Jan 2021
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Dec 2020
AIVITA Biomedical Closes $25 Million Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Dec 2020
Elevar Therapeutics Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea(R) (Paclitaxel Micellar) in Europe
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 21 Dec 2020
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Dec 2020
Leading BioSciences and Seneca Biopharma Announce Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Nov 2020
Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Nov 2020
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 12 Nov 2020
Discovery Life Sciences Launches TruSight Oncology 500 (TSO500) Solid Tumor FFPE and cfDNA Services to Advance Liquid Biopsy Development and Immunotherapy Clinical Research
Diagnostics Product Launch
 HSMN NewsFeed - 12 Oct 2020
Varian Receives Investigational Device Exemption (IDE) and Prepares for First Ever Clinical Trial of FLASH Therapy
Devices Oncology FDA
 HSMN NewsFeed - 7 Oct 2020
Lilly provides comprehensive update on progress of SARS-CoV-2 neutralizing antibody programs
Biopharmaceuticals
 HSMN NewsFeed - 14 Sep 2020
Varian Announces Appointment of Chris Toth as President and Chief Operating Officer
Devices Oncology Personnel
 HSMN NewsFeed - 26 Aug 2020
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
Diagnostics Neurology
 HSMN NewsFeed - 20 Aug 2020
Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 17 Aug 2020
DelMar Announces Approval of Merger by Stockholders
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 2 Aug 2020
Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2020
Long-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers
Devices Oncology
 HSMN NewsFeed - 22 Jun 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 8 Jun 2020
HistoSonics Announces $40 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 28 May 2020
RaySearch Enters Into Interoperability Agreement With Varian
Devices Oncology
 HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 May 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 21 May 2020
Varian Launches New Noona(R) Capabilities to Meet Growing Demand for Remote Cancer Patient Monitoring in Response to COVID-19's Impact on Healthcare
Devices Oncology Product Launch
 HSMN NewsFeed - 21 May 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 May 2020
ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
Diagnostics Oncology FDA
 HSMN NewsFeed - 20 Apr 2020
Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target Selector(TM) Technology Validated for Use in Both Tissue and Blood Samples
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 14 Apr 2020
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
Diagnostics Oncology Personnel
 HSMN NewsFeed - 9 Apr 2020
CrossRoads(R) Extremity Systems Unveils miniBunion(TM) Minimally-Invasive Bunion Correction Technique
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 31 Mar 2020
Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 25 Mar 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 17 Mar 2020
Alabama's Only Proton Therapy Center Treats First Patient with Varian ProBeam
Devices Oncology
 HSMN NewsFeed - 12 Mar 2020
ImmunoPrecise Announces the Launch of PolyTope mAb Therapy(TM) to Tackle Coronavirus Pandemic
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 3 Mar 2020
Smith & Nephew Announces US Launch of Pico(TM) 14 Single Use Negative Pressure Wound Therapy System for Use On High Risk Surgical Patients
Devices Wound Care Product Launch
 HSMN NewsFeed - 2 Mar 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
Devices Personnel
 HSMN NewsFeed - 11 Feb 2020
Caris Life Sciences Appoints New Executive Medical Director
Diagnostics Oncology Personnel
 HSMN NewsFeed - 5 Feb 2020
Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jan 2020
Varian Appoints Prof. Dr. Ricky Sharma VP of Clinical Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 13 Jan 2020
Bardy Diagnostics(TM) Names Ed Vertatschitsch as Chief Operating Officer and Announces Additions to the Leadership Team
Devices Monitoring Cardiology Personnel
 HSMN NewsFeed - 13 Jan 2020
CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 13 Jan 2020
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular Degeneration (AMD) and Diabetic Macular Edema
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 19 Dec 2019
MaxCyte Appoints New Executive Vice President, Business Development for CARMA(TM) Cellular Therapies and Provides Clinical Trial Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2019
Fluxion Launches Three New Spotlight(TM) Liquid Biopsy NGS Panels
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 10 Dec 2019
Shoulder Innovations Announces FDA 510(k) Clearance For InSet Plus(TM) Augmented Glenoids For Total Shoulder System
Devices Orthopaedic FDA
 HSMN NewsFeed - 9 Dec 2019
HIZENTRA(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Nov 2019
CNS Pharmaceuticals Entered $2.0 Million Sublicense Agreement with WPD Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Nov 2019
CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Nov 2019
Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Care
Devices Oncology
 HSMN NewsFeed - 28 Oct 2019
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Oct 2019
On Target Laboratories Appoints Vice President of Regulatory and Quality
Diagnostics Oncology Personnel
 HSMN NewsFeed - 15 Oct 2019
Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing and Doses First Patient in Phase 1/2 Study of First-in-Class RAD51 Inhibitor
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 14 Oct 2019
Paragon Genomics Introduces New CleanPlex(R) Hereditary Cancer Panel V2 At American Society For Human Genetics 2019 Annual Meeting
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 16 Sep 2019
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
Devices Oncology Product Launch
 HSMN NewsFeed - 9 Sep 2019
Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor
Diagnostics Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 4 Sep 2019
NW Bio Expands Senior Management Team With Dr. Kevin Duffy As Vice President, Medical Affairs & External Collaborations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Sep 2019
Laboratory for Advanced Medicine Receives FDA Breakthrough Device Designation for Liquid Biopsy Liver Cancer Detection Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 19 Aug 2019
Boston Scientific Closes Acquisition of BTG plc.
Devices Interventional Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2019
On Target Laboratories Announces Leadership Transition and Appoints Christopher Barys as Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 5 Aug 2019
AbbVie Submits New Drug Application to US FDA for Investigational Elagolix for Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Women
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2019
Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning
Devices Oncology
 HSMN NewsFeed - 15 Jul 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jul 2019
Leading US Proton Center Selects RayStation for Treatment Planning
Devices Radiology Oncology
 HSMN NewsFeed - 9 Jul 2019
BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2019
Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset
Devices Interventional Acquisitions
 HSMN NewsFeed - 25 Jun 2019
Nevro Announces Executive Appointments
Devices Personnel
 HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 21 May 2019
DelMar Pharmaceuticals Announces Expansion of Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 May 2019
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
Devices Oncology
 HSMN NewsFeed - 9 May 2019
Varian Acquires CyberHeart
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2019
Varian and Shandong Cancer Hospital Form Proton Therapy Clinical Application and Research Partnership in China
Devices Oncology
 HSMN NewsFeed - 3 May 2019
New Study From Invitae Highlights the Importance of Multigene Genetic Testing for Uterine Cancer Patients
Diagnostics Oncology
 HSMN NewsFeed - 3 May 2019
Caris Life Sciences Receives FDA Breakthrough Device Designation for MI Transcriptome(TM) Companion Diagnostic Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 1 May 2019
Variant Pharmaceuticals Has a New Name - ZyVersa Therapeutics, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2019
South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System
Devices Oncology
 HSMN NewsFeed - 25 Apr 2019
CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA(R) [Alpha1-Proteinase Inhibitor (Human)]
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 22 Apr 2019
Variant Pharmaceuticals Expands Development Focus Into $60+ Billion Anti-inflammatory Market with Worldwide License to Novel Inflammasome Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Apr 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Apr 2019
HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing
Devices Venture Capital
 HSMN NewsFeed - 4 Apr 2019
DelMar Pharmaceuticals Welcomes Dr. John de Groot, Chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Center, as founding member of the Company's Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Apr 2019
Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 11 Mar 2019
Varian and Tata Trusts Sign Framework Agreement for Advanced Cancer Care Solutions to Address Growing Need in India
Devices Oncology
 HSMN NewsFeed - 27 Feb 2019
Aprea Therapeutics Adds New Investor to Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Feb 2019
NW Bio Hires David Innes As Vice President, Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Feb 2019
Thermo Fisher Scientific's Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 7 Feb 2019
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jan 2019
Biocept Launches Liquid Biopsy Kits Intended to Broaden Use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNA
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 21 Jan 2019
Varian Installs Gantry for ProBeam Compact Proton Therapy System at New Treatment Center in Singapore
Devices Oncology
 HSMN NewsFeed - 17 Jan 2019
First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy
Devices Oncology
 HSMN NewsFeed - 24 Dec 2018
Varian U.S. Tariff Exclusion Request Granted for Halcyon Radiotherapy System for Cancer Treatments
Devices Oncology
 HSMN NewsFeed - 10 Dec 2018
New Study Published in Journal of Clinical Oncology Supports Universal Genetic Testing for all Breast Cancer Patients
Diagnostics Oncology
 HSMN NewsFeed - 3 Dec 2018
Variant Pharmaceuticals Secures $10 Million in Financing from Korean Company, Incon Co., Ltd.
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Nov 2018
FDA's Center for Devices and Radiological Health and Center for Drug Evaluation and Research on agency's warning to consumers about genetic tests that claim to predict patients' responses to specific medications
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 23 Oct 2018
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena(R) (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Oct 2018
Thermo Fisher Scientific CE Marks Oncomine Dx Target Test
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 16 Oct 2018
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 Oct 2018
Varian Expands Cancer Care Portfolio with Noona Healthcare Acquisition
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 11 Oct 2018
Paragon Genomics Introduces CleanPlex(R) UMI Panel for Ultrafast, Precise Analysis of Lung Cancer Hotspot Mutations at ASHG 2018
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 28 Sep 2018
ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2018
Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 12 Sep 2018
Dr. Jeff Balser Named to Varian Board of Directors
Devices Oncology Personnel
 HSMN NewsFeed - 7 Sep 2018
Varian Signs Partnership Agreement with Mediheal to Support Cancer Care in Kenya
Devices Oncology
 HSMN NewsFeed - 4 Sep 2018
Varian Installs Cyclotron for ProBeam Compact Proton Therapy System at Treatment Center in Florida
Devices Oncology
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Obtains Debt Facility from Silicon Valley Bank to Acquire and Advance Momelotinib
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 21 Aug 2018
Varian CEO Dow Wilson Joins USISPF Board of Directors
Devices Oncology Personnel
 HSMN NewsFeed - 15 Aug 2018
IGM Biosciences Appoints Julie Hambleton, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Aug 2018
Cumberland Pharmaceuticals Appoints New Senior Executive
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2018
Varian Announces Acquisition of humediQ Global GmbH
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 30 Jul 2018
Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 27 Jul 2018
PharmaMar Reaches an Agreement With Impilo Pharma, a Part of Immedica Group, for the Promotion and Distribution of Yondelis(R) in the Nordic Countries and Eastern Europe
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 24 Jul 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 25 Jun 2018
DelMar Pharmaceuticals Appoints World-Renowned Molecular Biologist Dr. Napoleone Ferrara to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2018
AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 14 Jun 2018
Varian Provides Update on Proposed Sirtex Acquisition
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Jun 2018
Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 7 Jun 2018
Egalet Appoints Industry Veteran John Varian to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2018
Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 May 2018
TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 May 2018
Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
Diagnostics Product Launch
 HSMN NewsFeed - 7 May 2018
Varian Acquires Taiwan Distributor
Devices Oncology Distribution Mergers & Acquisitions
 HSMN NewsFeed - 4 May 2018
Varian Notes Receipt of Competing Bid by Sirtex
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2018
TSO3 Details Results of Prion Inactivation Studies
Devices
 HSMN NewsFeed - 25 Apr 2018
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2018
SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Apr 2018
Varian Expands Capabilities of Halcyon Treatment System with New Imaging Technologies
Devices Oncology
 HSMN NewsFeed - 19 Apr 2018
Philips showcases dedicated radiation oncology workflow solutions spanning image acquisition to treatment planning at ESTRO 2018
Devices Radiology Oncology
 HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 9 Apr 2018
Fischer Medical Receives U.S. FDA 510(k) Clearance to Market Bloom2 Cardiac Stimulator
Devices Cardiology FDA
 HSMN NewsFeed - 23 Mar 2018
Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 16 Mar 2018
FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Mar 2018
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
Biopharmaceuticals Personalized Medicine Licensing
 HSMN NewsFeed - 6 Mar 2018
FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
Diagnostics Oncology FDA
 HSMN NewsFeed - 26 Feb 2018
Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test to Predict Treatment Response in Metastatic Disease
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 23 Feb 2018
Kazia Receives FDA Orphan Designation for GDC-0084
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Feb 2018
Varian Acquires Evinance Innovation, Inc.
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 6 Feb 2018
Grifols HyperRAB(R) (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2018
Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India
Devices Oncology Regulatory
 HSMN NewsFeed - 5 Feb 2018
Varian Acquires Mobius Medical Systems
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 30 Jan 2018
Varian Signs Agreement to Acquire Sirtex
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2018
MabVax Therapeutics Holdings, Inc. Provides Business Strategy Update
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jan 2018
Morphotek Announces FDA Acceptance Of Investigational New Drug Application For Next-Generation Farletuzumab Antibody-Drug Conjugate MORAb-202
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Jan 2018
Varian Halcyon Treatment System Receives Taiwan FDA Approval
Devices Oncology Regulatory
 HSMN NewsFeed - 27 Dec 2017
Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron's Petition to Rehear the Panel's Decision Affirming Merus' Inequitable Conduct Claim Against Regeneron
Biopharmaceuticals Oncology Litigation
 HSMN NewsFeed - 14 Dec 2017
Silk Therapeutics Appoints Dr. Rebecca Lacouture to Company President
Devices Personnel
 HSMN NewsFeed - 6 Dec 2017
Varian Halcyon Treatment System Receives ANVISA Registration in Brazil
Devices Oncology Regulatory
 HSMN NewsFeed - 27 Nov 2017
Laura Shawver, Ph.D., Appointed CEO of Synthorx
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2017
Arterys Completes Series B to Accelerate Product Commercialization
Devices Radiology Venture Capital
 HSMN NewsFeed - 13 Nov 2017
EMD Serono Receives FDA Approval for New GONAL-f(R) RFF Redi-ject(R) Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Nov 2017
Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems
Devices Oncology
 HSMN NewsFeed - 3 Nov 2017
Varian Selected in Multi-Year Project to Replace Radiotherapy Treatment Equipment at Copenhagen's Rigshospitalet and Herlev Hospital
Devices Oncology
 HSMN NewsFeed - 3 Nov 2017
ViewRay's MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender
Devices Oncology
 HSMN NewsFeed - 30 Oct 2017
Varian Names New Chief People Officer, SVP HR
Devices Oncology Personnel
 HSMN NewsFeed - 27 Oct 2017
AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Oct 2017
First Patients in US Treated with Varian HyperArc High Definition Radiotherapy
Devices Oncology
 HSMN NewsFeed - 19 Oct 2017
European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy(R) System
Devices Oncology Litigation
 HSMN NewsFeed - 17 Oct 2017
UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System
Devices Oncology
 HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 25 Sep 2017
TapImmune Appoints Peter Hoang as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Sep 2017
Varian Announces Penn Medicine Treats World's First Patient on Halcyon System
Devices Oncology
 HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Sep 2017
Varian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017
Devices Oncology
 HSMN NewsFeed - 15 Sep 2017
Myriad Genetics Announces Positive Data Supporting New riskScore(TM) Test at the 36th Annual Conference of the National Society of Genetic Counselors
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 7 Sep 2017
Hereditary Cancer Risk Assessment Is an Important Option for Prostate Cancer Patients during Prostate Cancer Awareness Month
Diagnostics Oncology
 HSMN NewsFeed - 6 Sep 2017
AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Sep 2017
Morphotek(R), Inc. Announces an Agreement with Fujirebio Diagnostics, Inc. to Commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab(R)
Biopharmaceuticals Diagnostics Oncology Licensing
 HSMN NewsFeed - 28 Aug 2017
MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
Diagnostics Venture Capital
 HSMN NewsFeed - 9 Aug 2017
Varian Medical Systems Signs Brachytherapy Applicator Distribution Agreement with Bionix Radiation Therapy
Devices Oncology Distribution
 HSMN NewsFeed - 8 Aug 2017
First Patient Treated with Varian HyperArc High Definition Radiotherapy
Devices Oncology
 HSMN NewsFeed - 7 Aug 2017
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Aug 2017
ArcherDX expands blood-based mutation assay portfolio with new myeloid panels
Diagnostics Product Launch
 HSMN NewsFeed - 25 Jul 2017
HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Jul 2017
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human])
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Jul 2017
Quest Diagnostics Launches QHerit(TM), a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines
Diagnostics Product Launch
 HSMN NewsFeed - 17 Jul 2017
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
Biopharmaceutical Neurology Venture Capital
 HSMN NewsFeed - 11 Jul 2017
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jul 2017
Gail S. Page Joins Chembio Diagnostics Board of Directors
Diagnostics HIV/AIDS Personnel
 HSMN NewsFeed - 22 Jun 2017
DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jun 2017
Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink(R) Tumor Biomarker Platform
Diagnostics Oncology Personnel
 HSMN NewsFeed - 14 Jun 2017
Twist Bioscience Raises Additional $27 Million
Biopharmaceuticals Diagnostics Venture Capital
 HSMN NewsFeed - 24 May 2017
Varian Selected to Provide First Proton Therapy System in Thailand
Devices Oncology
 HSMN NewsFeed - 10 May 2017
Varian ProBeam Proton Therapy System Receives Shonin Approval
Devices Oncology Regulatory
 HSMN NewsFeed - 8 May 2017
New Varian Cancer Treatment Platform Draws Large Crowds at ESTRO 36 Tradeshow
Devices Oncology
 HSMN NewsFeed - 5 May 2017
Ram Group Next Generation Sensor Platform Will Bring Point-of-Care Diagnostics and Wearables to Emerging Markets to Address Global Health Issues
Diagnostics Monitoring
 HSMN NewsFeed - 28 Apr 2017
Invivoscribe(R) Receives FDA Approval for the LeukoStrat(R) CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt(R) and is the First Companion Diagnostic for AML
Diagnostics Personalized Medicine Oncology FDA
 HSMN NewsFeed - 10 Apr 2017
First-Ever Live Laparoscopic Surgery Using Image-Guided Robotically Assisted System
Devices Surgery
 HSMN NewsFeed - 5 Apr 2017
Varian Medical Systems Names New CFO
Devices Oncology Personnel
 HSMN NewsFeed - 4 Apr 2017
Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2017
CytomX Therapeutics Appoints Marion McCourt to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 28 Mar 2017
Personal Genome Diagnostics' Expanded PlasmaSELECT(TM) 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 27 Mar 2017
Twist Bioscience Raises $33 Million
Biopharmaceuticals Diagnostics Venture Capital
 HSMN NewsFeed - 27 Mar 2017
Bovie Medical Receives 510K Clearance for Its Cool-Coag(TM) Generator and Open Handpiece
Devices Surgery FDA
 HSMN NewsFeed - 20 Mar 2017
Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody(TM) Therapeutics for the Treatment of Cancer and Other Diseases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Mar 2017
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Mar 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
Devices Oncology Personnel
 HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Feb 2017
Syndax Appoints Richard P. Shea as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Jan 2017
Varian Medical Systems Announces Distribution Ratio And Record Date For Separation Of Imaging Components Business
Devices Radiology Oncology
 HSMN NewsFeed - 9 Jan 2017
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 23 Dec 2016
Dipexium and PLx Pharma Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Dec 2016
Foundation Medicine Receives FDA Approval of FoundationFocus(TM) CDxBRCA as a Companion Diagnostic for Rubraca(TM) (rucaparib) for the Treatment of Women with Ovarian Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 15 Dec 2016
Brainlab ExacTrac Integrates Varian’s PerfectPitch to Enable Highly Accurate Radiosurgery Treatments With Advanced 6D Correctional Accuracy
Devices Oncology Neurosurgery Product Launch
 HSMN NewsFeed - 7 Dec 2016
Panther Biotechnology Receives Positive Feedback from the FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Dec 2016
Exonate Closes Successful Funding Round - To Develop Eye Drops Treatment for Wet Age-related Macular Degeneration (Wet AMD)
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 7 Nov 2016
Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDx(R)
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 2 Nov 2016
Verastem Licenses Duvelisib from Infinity Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 31 Oct 2016
European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Oct 2016
USITC Publishes Initial Determination in Litigation Dispute
Devices Oncology Litigation
 HSMN NewsFeed - 31 Oct 2016
Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in Glioblastoma
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 28 Oct 2016
Astellas to Acquire Ganymed Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Oct 2016
Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 19 Oct 2016
SELLAS(TM) Life Sciences Appoints Former Barclays Biotechnology Research Analyst as Chief Business and Strategy Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2016
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2016
Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Sep 2016
Varian Exhibiting New HyperArc Technology for High Definition Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 15 Sep 2016
Varian Medical Systems Receives FDA 510(k) Clearance for Nexus DR Digital X-Ray Imaging System
Devices Radiology Oncology FDA
 HSMN NewsFeed - 9 Sep 2016
Prospective, independent study demonstrates the utility of Guardant360 for guiding therapy selection in advanced Non-Small-Cell Lung Cancer
Diagnostics Oncology
 HSMN NewsFeed - 6 Sep 2016
OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Sep 2016
Eisai Bewildered as German Institute for Quality and Efficiency in Health Care (IQWIG) Fails to Recognise Additional Benefit of Halaven(R) (eribulin) in the Treatment of Advanced Liposarcoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Aug 2016
Judy Bruner Appointed to Board of Directors of Varian Medical Systems; Venkatraman Thyagarajan Retires from Varian Board
Devices Oncology Personnel
 HSMN NewsFeed - 2 Aug 2016
Accera Appoints C. Evan Ballantyne as Chief Financial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Aug 2016
Varian Medical Systems Selected to Supply First Modern Radiotherapy Systems in Ethiopia
Devices Oncology
 HSMN NewsFeed - 14 Jul 2016
Accuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline Report
Devices Oncology Neurosurgery
 HSMN NewsFeed - 10 Jun 2016
AiVita Biomedical Raises $2m in Series A Financing for Commercial and Clinical-Stage Program Development
Regenerative Medicine Venture Capital Personnel
 HSMN NewsFeed - 9 Jun 2016
Varian and Russian Proton Therapy Center Achieve Milestone with Cyclotron Installation
Devices Oncology
 HSMN NewsFeed - 2 Jun 2016
FDA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 May 2016
Accera Completes Enrollment of Phase 3 NOURISH AD Study of AC-1204 for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Apr 2016
Varian Gives European Clinicians First Glimpse of Next Big Advance in Radiotherapy at ESTRO 35
Devices Oncology
 HSMN NewsFeed - 27 Apr 2016
Proton Therapy Center Initiates 3D Image Guided Proton Therapy to Enhance Precision of Cancer Care
Devices Oncology
 HSMN NewsFeed - 21 Apr 2016
FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Apr 2016
AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2016
Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Apr 2016
Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2016
Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 22 Mar 2016
Varian Launches New Smaller Calypso Beacon Transponder To Guide Radiation Therapy In Soft Tissue Tumors
Devices Oncology FDA Regulatory Product Launch
 HSMN NewsFeed - 21 Mar 2016
Tokai Strengthens Development Team Through the Addition of Kelly Lindert, M.D., as Executive Vice President and Head of Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Mar 2016
The Myriad myRisk(R) Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 16 Mar 2016
Ember Therapeutics Enhances Regenerative Medicine Pipeline With Acquisition of ICX-RHY/Vavelta(TM) from Intercytex
Regenerative Medicine Dermatology Acquisitions
 HSMN NewsFeed - 9 Mar 2016
Karolinska Development's Portfolio Company Aprea Raises SEK 437 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Mar 2016
Accera Appoints Ernest Wong, Ph.D., as Head of Corporate Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 19 Feb 2016
Novogen Patent Covering Cantrixil and Trilexium has Proceeded to Grant
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2016
TapImmune Granted Fast Track Designation by U.S. Food & Drug Administration for its Lead Vaccine TPIV 200 in the Treatment of Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Jan 2016
Merck Receives FDA Approval of ZEPATIER(TM) (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 26 Jan 2016
Varian Medical Systems Appoints Dr. Patrick Kupelian VP of Clinical Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 26 Jan 2016
Abcodia Announces Expanded U.S. Availability of the ROCA(R) Test for Early Ovarian Cancer Detection
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 20 Jan 2016
Allan L. Shaw Joins Syndax Pharmaceuticals As Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jan 2016
Oncimmune Appoints Greg Stanley as President of Commercial Operations
Diagnostics Oncology Personnel
 HSMN NewsFeed - 19 Jan 2016
ZipLine(R) Medical Secures $19 Million Financing Led by New Investor, MVM Life Science Partners LLP
Devices Surgery Venture Capital
 HSMN NewsFeed - 19 Jan 2016
Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jan 2016
MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline
Diagnostics Oncology Personnel
 HSMN NewsFeed - 8 Jan 2016
Dr. Rolf Muller Appointed as New CEO of BioFluidica, Inc.
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jan 2016
OvaScience Names Harald F. Stock Chief Executive Officer-Elect
Devices Personnel
 HSMN NewsFeed - 7 Dec 2015
Nemucore Medical Innovations Completes Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 Nov 2015
Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 18 Nov 2015
Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Oct 2015
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Oct 2015
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
Biopharmaceuticals
 HSMN NewsFeed - 14 Oct 2015
Eclipse(TM) Treatment Planning Software from Varian Now Offers Robust Optimization and Proton Therapy Dose Calculation Tools
Devices Oncology FDA Product Launch
 HSMN NewsFeed - 12 Oct 2015
Varian Medical Systems Receives CE Mark for its Latest ProBeam(R) Proton Therapy System
Devices Oncology Regulatory
 HSMN NewsFeed - 29 Sep 2015
Elekta States That Varian Claims Lack Merit
Devices Oncology Litigation
 HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Sep 2015
Cerulean Appoints David R. Walt, Ph.D. to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Sep 2015
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2015
Tokai Pharmaceuticals Augments Commercialization Capabilities through Appointment of Lisa Taylor as Senior Vice President, Commercial Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Aug 2015
FDA Approves Taro’s Keveyis(TM) (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Aug 2015
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jul 2015
Kailos Genetics Hires Cheri Walker as Chief Financial Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 27 Jul 2015
Varian Signs Contracts to Equip Two National Proton Therapy Centers in England
Devices Oncology
 HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jul 2015
Theranos Receives First FDA Clearance for Finger Stick and Venous Blood Test and Independent FDA Review and Validation of its Underlying Theranos System for Herpes Simplex Virus-1 Diagnosis
Diagnostics FDA
 HSMN NewsFeed - 1 Jul 2015
Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product
Diagnostics Oncology Personnel
 HSMN NewsFeed - 29 May 2015
Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ASCO Annual Meeting
Diagnostics Oncology
 HSMN NewsFeed - 14 May 2015
EPIRUS Biopharmaceuticals and mAbxience Sign Latin America Distribution Deal for Infliximab Biosimilar, BOW015
Biopharmaceuticals Distribution
 HSMN NewsFeed - 12 May 2015
Aspyrian Therapeutics Inc. Announces FDA Acceptance of an Investigational New Drug Application for RM-1929, a First-in-Class, Precision-Targeted Therapy for Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 May 2015
RaySearch Laboratories: First Proton Treatments with RayStation and MEVION S250
Devices Oncology Product Launch
 HSMN NewsFeed - 20 Apr 2015
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 8 Apr 2015
Alzheon Announces $10 Million Series A Financing
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Apr 2015
FDA Expands Indication for EVARREST(R) Fibrin Sealant Patch
Devices Surgery FDA
 HSMN NewsFeed - 25 Mar 2015
VBL Therapeutics Reports Interim Topline Results From Phase 2 Clinical Trial of VB-111 in Recurrent Glioblastoma (rGBM)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2015
OXiGENE, Inc. Announces $10 Million At-the-Market Registered Direct Offering
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Mar 2015
Varian Medical Systems Selected to Equip Two National Proton Therapy Centers in England
Devices Oncology
 HSMN NewsFeed - 4 Mar 2015
Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC(R), a Prostate-Specific Antigen-Targeting Cancer Immunotherapy
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 27 Feb 2015
Varian Medical Systems to Make Radiotherapy Available for More Cancer Patients in Africa
Devices Oncology
 HSMN NewsFeed - 23 Feb 2015
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2015
U.S. FDA Grants Priority Review for YONDELIS(R) (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2015
CTI BioPharma Announces Independent DMC Recommendation to Continue GOG-0212 Phase 3 Study of OPAXIO(TM) as Maintenance Therapy in Ovarian Cancer, an NRG Oncology/GOG Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jan 2015
Cerulean Appoints Vice President, Clinical Operations
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 27 Jan 2015
ONCOLIX, INC. Announces Capital Raise of $4.2 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Jan 2015
Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 5 Jan 2015
Aduro Biotech Closes $51.4 Million Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Dec 2014
Oncolytics Biotech(R) Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Pancreatic and Ovarian Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Oct 2014
RaySearch Laboratories: Raysearch Receives FDA Clearance for RayStation 4.5 Featuring Ultrafast and Robust Optimization
Devices Oncology FDA
 HSMN NewsFeed - 24 Oct 2014
Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe
Diagnostics Oncology
 HSMN NewsFeed - 11 Sep 2014
Cyclacel Pharmaceuticals Appoints Samuel L. Barker, Ph.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Sep 2014
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2014
Vermillion Announces Additions to Commercial Management Team
Diagnostics Personnel
 HSMN NewsFeed - 30 Jul 2014
Study Shows that RapidArc(R) Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife(R) in the Treatment of Multiple Brain Metastases
Devices Oncology
 HSMN NewsFeed - 28 Jul 2014
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jul 2014
Varian Medical Systems Receives FDA 510(k) Clearance for Calypso(R) Soft Tissue Beacon(R) Transponder
Devices Oncology FDA
 HSMN NewsFeed - 17 Jul 2014
Edico Genome Raises $10 Million in Series A Financing to Commercialize DRAGEN Chip to Overcome Sequencing Data Analysis Bottleneck
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 7 Jul 2014
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
Diagnostics Personnel
 HSMN NewsFeed - 20 Jun 2014
ERBA Diagnostics, Inc. Appoints William Creech as Vice President Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 13 Jun 2014
Varian Medical Systems to Equip Prime Healthcare Services Hospitals with Varian Technology for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 13 Jun 2014
EntreMed Stockholders Approve Name Change To CASI Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2014
Doctors at Community Cancer Center Treat Inoperable Lung Cancer Using TrueBeam System for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 2 Jun 2014
Myriad Presents Clinical Data on Myriad myRisk(TM) Hereditary Cancer Test at ASCO
Diagnostics Oncology
 HSMN NewsFeed - 29 May 2014
Aduro Announces License Agreement with Johnson & Johnson Innovation for Novel Immunotherapies for Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 27 May 2014
Varian Medical Systems To Equip New Proton Treatment Center at the National Taiwan University in Taipei
Devices Oncology
 HSMN NewsFeed - 27 May 2014
Bristol-Myers Squibb and Incyte Enter Clinical Collaboration Agreement to Evaluate Combination Regimen of Two Novel Immunotherapies
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2014
RaySearch Laboratories: RaySearch receives 510(k) clearance for Pencil Beam Scanning with protons
Devices Oncology FDA
 HSMN NewsFeed - 19 May 2014
Pamela Youde Nethersole Eastern Hospital First in Asia to Treat Cancer using TrueBeam 2.0 System for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2014
Prima BioMed's CVac(TM) Granted Fast Track Designation by FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 May 2014
Myriad and UnitedHealthcare Sign Three-Year Agreement Making myRisk(TM) Hereditary Cancer Test Available to United Members
Diagnostics Oncology
 HSMN NewsFeed - 2 May 2014
Merck and Endocyte Announce Independent DSMB Recommends Vintafolide PROCEED Phase 3 Trial Be Stopped for Futility Following Interim Analysis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 May 2014
Myriad to Launch EndoPredict(R) in Canada
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 28 Apr 2014
Vermillion Launches ASPiRA LABS
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 25 Apr 2014
Chugai Pharma USA Announces Appointment of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2014
Epirus and Zalicus Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Venture Capital
 HSMN NewsFeed - 16 Apr 2014
Provista Diagnostics Secures $6MM Series B Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 2 Apr 2014
Leading Cancer Center in Italy Introduces Wider Range of Non-Surgical Cancer Treatments Using Varian's Edge(TM) Radiosurgery System
Devices Oncology
 HSMN NewsFeed - 27 Mar 2014
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2014
Zogenix Appoints James Breitmeyer to Its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Mar 2014
 Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT(R) (vintafolide) and Companion Imaging Agents FOLCEPRI(R) (etarfolatide) and NEOCEPRI(R) (Intravenous (IV) folic acid) in Patients with Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology Radiology Regulatory
 HSMN NewsFeed - 19 Mar 2014
RaySearch Secures Distribution of Raystation(R) in Australia and New Zealand
Devices Oncology Distribution
 HSMN NewsFeed - 17 Mar 2014
Veracyte, Inc. Appoints Julie A. Brooks as Executive Vice President, General Counsel and Secretary; and Andy Thorson as Executive Vice President, Corporate Strategy and Business Development
Diagnostics Personnel
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 6 Mar 2014
Varian Medical Systems to Exhibit Wireless Flat Panel Detectors, X-Ray Tubes for Digital Radiography and Image Processing Software at the European Congress of Radiology
Devices Radiology Oncology
 HSMN NewsFeed - 5 Mar 2014
Leading Cancer Center in Portugal Becomes First in World to Offer Edge(TM) Radiosurgery
Devices Oncology
 HSMN NewsFeed - 28 Feb 2014
InterMune(R) Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2014
Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy Testing for Colorectal Cancer
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 7 Feb 2014
BRCA Patent Owners and Gene by Gene, Ltd. Resolve Patent Suit
Diagnostics Oncology Litigation
 HSMN NewsFeed - 31 Jan 2014
RaySearch Laboratories: First RayStation(R) Order in the United Kingdom
Devices Oncology
 HSMN NewsFeed - 21 Jan 2014
Affymetrix Receives FDA Clearance of First-of-its-kind Postnatal Test for Developmental Delays and Intellectual Disabilities in Children
Diagnostics FDA
 HSMN NewsFeed - 15 Jan 2014
Varian Medical Systems Receives FDA 510(k) Clearance for its ProBeam(TM) Proton Therapy System
Devices Oncology FDA
 HSMN NewsFeed - 15 Jan 2014
AbbVie Announces Initiation of Pivotal Phase 3 Study of Veliparib (ABT-888) for Patients with Early-Stage Triple-Negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Jan 2014
Lion Biotechnologies Appoints James Bender, Ph.D., as Vice President, Product Development and Manufacturing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Dec 2013
RaySearch Laboratories: Dutch Clinic Selects RayStation(R)
Devices Oncology
 HSMN NewsFeed - 23 Dec 2013
RaySearch Laboratories: ProCure Proton Centers Select RayStation(R) for Proton Planning
Devices Oncology
 HSMN NewsFeed - 20 Dec 2013
RaySearch Laboratories: Columbia University Hospital – New York City extends clinical partnership with RaySearch
Devices Radiology Oncology
 HSMN NewsFeed - 20 Dec 2013
RaySearch Laboratories: License agreement with TomoTherapy terminated
Devices Radiology Licensing
 HSMN NewsFeed - 19 Dec 2013
Baxter Receives FDA Approval of FEIBA [Anti-Inhibitor Coagulant Complex] for Prophylactic Treatment of Hemophilia A&B Patients with Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 16 Dec 2013
Varian Imaging Components President Robert Kluge Announces Plans to Retire; Varian CEO Dow Wilson Names Sunny Sanyal as Kluge's Successor
Devices Radiology Oncology Personnel
 HSMN NewsFeed - 12 Dec 2013
Myriad myRisk Hereditary Cancer(TM) Test Significantly Improves Detection of Women at Risk for Hereditary Cancer by 51 Percent
Diagnostics Oncology
 HSMN NewsFeed - 9 Dec 2013
Myriad Genetics Announces Cancer Research Collaboration With Janssen
Diagnostics Oncology
 HSMN NewsFeed - 27 Nov 2013
Study Suggests Non-Invasive Stereotactic Ablative Body Radiotherapy May Be Suitable Alternative to Surgery for Early-Stage Lung Cancer Patients
Devices Oncology
 HSMN NewsFeed - 27 Nov 2013
Over 110 Attend First Varian Edge(TM) Radiosurgery Symposium to Discuss Advances in Stereotactic Radiosurgery and Stereotactic Ablative Radiotherapy
Devices Oncology
 HSMN NewsFeed - 25 Nov 2013
Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the SEAMLESS Phase 3 Trial of Sapacitabine in AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Nov 2013
3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Nov 2013
Myriad Genetics Launches myPath(TM) Melanoma Diagnostic Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 4 Nov 2013
RaySearch Enters into Distribution Agreement with Hitachi Medical Corporation
Devices Oncology Distribution
 HSMN NewsFeed - 31 Oct 2013
Stem Cell Therapeutics Receives U.S. Orphan Drug Designation for the Use of Tigecycline to Treat Acute Myeloid Leukemia
Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 29 Oct 2013
Myriad myPlan(TM) Lung Cancer Test Launched to Leading Oncologists
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 24 Oct 2013
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
Diagnostics Oncology
 HSMN NewsFeed - 16 Oct 2013
Seragon Pharmaceuticals Raises $30M in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Oct 2013
RaySearch Laboratories: University Medical Center Groningen and RaySearch Initiate Collaboration within Adaptive Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 10 Oct 2013
RaySearch Laboratories: Institut Paoli-Calmettes becomes first RayStation(R) reference clinic in France
Devices Oncology
 HSMN NewsFeed - 9 Oct 2013
RaySearch Laboratories: First RayStation(R) Order in Scandinavia
Devices Radiology Oncology
 HSMN NewsFeed - 7 Oct 2013
Personalis Closes $22M Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Sep 2013
Varian Medical Systems Announces First Orders of the Edge(TM) Radiosurgery Suite -- A Comprehensive Solution for Non-Invasive Surgical Procedures
Devices Oncology Product Launch
 HSMN NewsFeed - 16 Sep 2013
Quidel Receives Two FDA Clearances for Molecular Diagnostic Tests for Use on Life Technologies QuantStudio(TM) Dx
Diagnostics FDA
 HSMN NewsFeed - 13 Sep 2013
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
Diagnostics Personnel
 HSMN NewsFeed - 9 Sep 2013
Assurex Health Appoints Veteran P&G Consumer Products Executive Virginia Coleman Drosos President to Lead Personalized Medicine Growth
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 5 Sep 2013
Myriad Genetics Launches myRisk(TM) Hereditary Cancer Panel
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 26 Aug 2013
RaySearch Laboratories: First RayStation(R) order in China
Devices Oncology
 HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 23 Aug 2013
RaySearch Laboratories: Provision Center for Proton Therapy Selects RayStation(R)
Devices Oncology
 HSMN NewsFeed - 19 Aug 2013
Provista Diagnostics Appoints Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 13 Aug 2013
Elekta: Lawsuit with Varian Medical Systems resolved
Devices Oncology Litigation
 HSMN NewsFeed - 30 Jul 2013
Sialix Raises $1.0 Million in Second Round of Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 29 Jul 2013
Perrigo Company to Acquire Elan Corporation, plc for US$8.6 Billion, Establishing Premier Global Healthcare Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jul 2013
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jul 2013
RaySearch Laboratories: RayStation(R) 4.0 Released
Devices Oncology Product Launch
 HSMN NewsFeed - 17 Jul 2013
Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 3 Jul 2013
Seattle's Swedish Cancer Institute Acquires Four Elekta Versa HD Radiation Therapy Systems
Devices Oncology
 HSMN NewsFeed - 1 Jul 2013
Illumina Applies CE Mark to MiSeqDx(TM) Cystic Fibrosis System
Diagnostics Regulatory
 HSMN NewsFeed - 13 Jun 2013
Supreme Court Upholds Myriad's cDNA Patent Claims
Diagnostics Oncology Litigation
 HSMN NewsFeed - 13 Jun 2013
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 12 Jun 2013
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2013
NW Bio Initiates Phase III DCVax(R)-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2013
FANG(TM) Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 15 May 2013
RaySearch Laboratories: RaySearch receives 510(k) clearance for RayStation(R) 3.5
Devices Oncology FDA
 HSMN NewsFeed - 23 Apr 2013
VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2013
ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for Gencaro(TM)
Biopharmaceuticals Devices Monitoring Cardiology
 HSMN NewsFeed - 16 Apr 2013
Prostate Cancer Patient Receives First Treatment Using Latest Version of Vitesse Real-Time Brachytherapy Planning System from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 11 Apr 2013
Varian Medical Systems to Exhibit TrueBeam(TM) System for Image-Guided Radiotherapy and Radiosurgery at ITEM Exhibition in Yokohama, Japan
Devices Oncology
 HSMN NewsFeed - 10 Apr 2013
Lilly Debuts Early Oncology Pipeline Data At AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Mar 2013
Varian Medical Systems Appoints Deepak "Dee" Khuntia M.D. Vice President of Medical Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 15 Mar 2013
RaySearch Laboratories: RayStation(R) 3.5 Released
Devices Oncology Product Launch
 HSMN NewsFeed - 13 Mar 2013
Vermillion Appoints Thomas McLain as President and Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 11 Mar 2013
Precision Therapeutics Announces Topline Prospective Clinical Data Demonstrating Significant Improvement in Overall Survival and Progression Free Survival in Recurrent Ovarian Cancer using Personalized Chemotherapy Diagnostic ChemoFx(R)
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 6 Mar 2013
Elekta: Kuopio University Hospital First in Finland with Elekta’s New Beam Shaping Innovation for Radiotherapy of Cancer Patients
Devices Oncology
 HSMN NewsFeed - 5 Mar 2013
Varian Medical Systems to Showcase Fast, Reliable, Wireless X-ray Image Detectors at the ECR Annual Meeting in Vienna Next Week
Devices Radiology
 HSMN NewsFeed - 4 Mar 2013
The Radiosurgery Society(TM) Completes the 2013 Scientific Meeting Focused on Bridging the Gap: Working Together
Devices Oncology
 HSMN NewsFeed - 22 Feb 2013
EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer
Devices Urology Oncology
 HSMN NewsFeed - 14 Feb 2013
Verastem Files for Orphan Disease Status for VS-6063 in Mesothelioma
Biopharmaceuticals Oncology Regulatory FDA
 HSMN NewsFeed - 7 Feb 2013
Amgen Outlines Long-Term Strategy
Biopharmaceuticals
 HSMN NewsFeed - 28 Jan 2013
New NCCN Guidelines for Patients(R) Available for Adolescents and Young Adults with Cancer
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 24 Jan 2013
Varian Medical Systems Receives FDA 510(k) Clearance for Vitesse(TM) Brachytherapy Treatment Planning Software
Devices Oncology FDA
 HSMN NewsFeed - 24 Jan 2013
Varian Medical Systems Receives FDA 510(k) Clearance for the Edge(TM) Radiosurgery Suite for Non-Invasive Surgical Procedures
Devices Oncology FDA
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 7 Jan 2013
Covidien’s Tri-Staple(TM) Technology Platform Reaches $1 Billion Sales Milestone
Devices Surgery
 HSMN NewsFeed - 3 Jan 2013
Gradalis, Inc. Closes $24 Million in Series B Financing to Advance Late-Stage Trials of FANG(TM) Personalized Cancer Vaccine
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Jan 2013
RaySearch Laboratories: RaySearch and Siemens dissolve partnership
Devices Oncology Licensing
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Varian
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.